Joinn Laboratories (China) Co (SHSE:603127) Piotroski F-Score: 6 (As of Aug. 01, 2026) — 20% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603127 Joinn Laboratories (China) Co Ltd SHSE:603127
78 GF Score
Price ¥41.54
GF Value ¥17.43
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Joinn Laboratories (China) Co Piotroski F-Score?

Joinn Laboratories (China) Co SHSE:603127 +3.72% 78 Piotroski F-Score is 6 as of Aug. 01, 2026, which is 20% above its 10-year median of 5.00. GuruFocus rates SHSE:603127 with a GF Score™ of 78/100 and a GF Value™ of ¥17.43 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 207 Medical Diagnostics & Research companies, Joinn Laboratories (China) Co ranks better than 80.19% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Joinn Laboratories (China) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Joinn Laboratories (China) Co's Piotroski F-Score or its related term are showing as below:

SHSE:603127' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Joinn Laboratories (China) Co was 9. The lowest was 3. And the median was 5.

Joinn Laboratories (China) Co  (SHSE:603127) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Joinn Laboratories (China) Co Piotroski F-Score Related Terms


Joinn Laboratories (China) Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Joinn Laboratories (China) Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joinn Laboratories (China) Co Piotroski F-Score Chart

Joinn Laboratories (China) Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 3.00 5.00 5.00 6.00

Joinn Laboratories (China) Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 7.00 7.00 6.00 6.00

SHSE:603127 vs TMO, DHR, IDXX: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joinn Laboratories (China) Co Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's Piotroski F-Score falls into.


SHSE:603127
78GF Score
Joinn Laboratories (China) Co Ltd SHSE:603127
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 19.813 + 19.774 + 217.135 + 238.357 = ¥495 Mil.
Cash Flow from Operations was 97.624 + 103.618 + 178.176 + 127.611 = ¥507 Mil.
Revenue was 381.238 + 316.386 + 672.663 + 316.135 = ¥1,686 Mil.
Gross Profit was 78.436 + 51.64 + 131.032 + 64.763 = ¥326 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(9424.659 + 9473.462 + 9533.383 + 9681.909 + 10036.866) / 5 = ¥9630.0558 Mil.
Total Assets at the begining of this year (Mar25) was ¥9,425 Mil.
Long-Term Debt & Capital Lease Obligation was ¥12 Mil.
Total Current Assets was ¥5,067 Mil.
Total Current Liabilities was ¥1,262 Mil.
Net Income was 102.48 + 99.436 + 144.382 + 41.119 = ¥387 Mil.

Revenue was 524.547 + 485.8 + 683.178 + 287.337 = ¥1,981 Mil.
Gross Profit was 151.281 + 108.971 + 206.869 + 82.204 = ¥549 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(9733.254 + 9661.274 + 9525.185 + 9396.153 + 9424.659) / 5 = ¥9548.105 Mil.
Total Assets at the begining of last year (Mar24) was ¥9,733 Mil.
Long-Term Debt & Capital Lease Obligation was ¥21 Mil.
Total Current Assets was ¥5,064 Mil.
Total Current Liabilities was ¥1,098 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Joinn Laboratories (China) Co's current Net Income (TTM) was 495. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Joinn Laboratories (China) Co's current Cash Flow from Operations (TTM) was 507. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=495.079/9424.659
=0.05253018

ROA (Last Year)=Net Income/Total Assets (Mar24)
=387.417/9733.254
=0.03980344

Joinn Laboratories (China) Co's return on assets of this year was 0.05253018. Joinn Laboratories (China) Co's return on assets of last year was 0.03980344. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Joinn Laboratories (China) Co's current Net Income (TTM) was 495. Joinn Laboratories (China) Co's current Cash Flow from Operations (TTM) was 507. ==> 507 > 495 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=12.476/9630.0558
=0.00129553

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=20.997/9548.105
=0.00219908

Joinn Laboratories (China) Co's gearing of this year was 0.00129553. Joinn Laboratories (China) Co's gearing of last year was 0.00219908. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=5067.306/1261.545
=4.01674613

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=5063.761/1097.659
=4.6132369

Joinn Laboratories (China) Co's current ratio of this year was 4.01674613. Joinn Laboratories (China) Co's current ratio of last year was 4.6132369. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Joinn Laboratories (China) Co's number of shares in issue this year was 744.865. Joinn Laboratories (China) Co's number of shares in issue last year was 822.39. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=325.871/1686.422
=0.19323218

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=549.325/1980.862
=0.27731614

Joinn Laboratories (China) Co's gross margin of this year was 0.19323218. Joinn Laboratories (China) Co's gross margin of last year was 0.27731614. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=1686.422/9424.659
=0.17893719

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1980.862/9733.254
=0.20351488

Joinn Laboratories (China) Co's asset turnover of this year was 0.17893719. Joinn Laboratories (China) Co's asset turnover of last year was 0.20351488. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Joinn Laboratories (China) Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Joinn Laboratories (China) Co (SHSE:603127) has a Piotroski F-Score of 6 as of Aug. 01, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Joinn Laboratories (China) Co and its competitors. This is 20% above median its historical median of 5.00. Over the past decade, Joinn Laboratories (China) Co's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Joinn Laboratories (China) Co ranks #41 out of 207 companies in the Medical Diagnostics & Research industry, placing it in the top 19.8%.
Is Joinn Laboratories (China) Co's Piotroski F-Score too high?
Joinn Laboratories (China) Co's current Piotroski F-Score of 6 is 20% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Joinn Laboratories (China) Co's value of 6 is 20% above this industry median. Based on the distribution chart, Joinn Laboratories (China) Co ranks #41 out of 207 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Joinn Laboratories (China) Co has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Joinn Laboratories (China) Co's Piotroski F-Score compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Joinn Laboratories (China) Co ranks #41 out of 207 companies for Piotroski F-Score. This places Joinn Laboratories (China) Co in the top 20% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Joinn Laboratories (China) Co's value of 6 is 20% above this benchmark. Historically, Joinn Laboratories (China) Co's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Joinn Laboratories (China) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Joinn Laboratories (China) Co's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Joinn Laboratories (China) Co and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Joinn Laboratories (China) Co's current Piotroski F-Score is 6, which is 20% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joinn Laboratories (China) Co stock overvalued right now?
Based on GuruFocus' analysis, Joinn Laboratories (China) Co (SHSE:603127) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.43, compared to a current price of ¥41.54 — trading 138.3% above its estimated fair value. The current Piotroski F-Score is 6, which is 20% above median its 10-year median of 5.00 and 20% above the Medical Diagnostics & Research industry median of 5.00. Joinn Laboratories (China) Co's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Joinn Laboratories (China) Co (SHSE:603127), the current Piotroski F-Score is 6 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Joinn Laboratories (China) Co (SHSE:603127) Overvalued in 2026?

Based on GuruFocus' analysis, Joinn Laboratories (China) Co stock appears to be overvalued. The current stock price of ¥41.54 is trading 138.3% above its estimated GF Value™ of ¥17.43. GuruFocus considers Joinn Laboratories (China) Co to be Significantly Overvalued.

Key valuation signals for SHSE:603127:

  • Piotroski F-Score: 6 (20% above median its 10-year median of 5.00)
  • GF Value™: ¥17.43 vs. price of ¥41.54 (138.3% above fair value)
  • GF Score™: 78/100 with 4 warning signs
  • Industry Position: 20% above the Medical Diagnostics & Research median (#41 of 207)

No single metric tells the full story. See the SHSE:603127 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Joinn Laboratories (China) Co Business Description

Other Exchanges 06127:Hong Kong
Address A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176
Joinn Laboratories (China) Co Ltd is a PRC-based company, along with its subsidiary, it is engaged in contract research organisation (CRO) services. It operates in three segments: Non-clinical studies services offer drug safety assessment, drug metabolism and pharmacokinetics (DMPK) studies, and pharmacology and efficacy studies; Clinical trial & related services provide clinical CRO services, co-managed phase I clinical research units, and bioanalytical servicesl services; and Sales of research models engages in the design, production, breeding and sales of research models, non-human primates and rodents. The majority of revenue comes from the Non-Clinical studies services. Its geographical areas are China, the United States, and Other countries, of which the majority are from China.
78GF Score

Get the complete analysis for SHSE:603127

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥41.54
Price
¥17.43
GF Value